Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

FPIM

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$16M
Portfolio companies 3
Lead investments 0
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Renewable Energy
  • Chemical
  • Pharmaceutical
  • Manufacturing

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of FPIM:
Typical Co-investors
FPIM is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after FPIM:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Bremer Tageszeitungen AG -
CAPNOVA Aarhus, Denmark, Midtjylland
Centre for Commercialization of Regenerative Medicine Canada, Ontario, Toronto
Disruptive Technologies Bergen, Hordaland, Norway
Galvanise Capital England, London, United Kingdom
Goodbye Kansas Game Invest Stockholm, Stockholm County, Sweden
Griffith Foods Alsip, Illinois, United States
Guohong Zhisheng Venture Capital China, Shanghai
Innoport Germany, Hamburg
Kohlberg Ventures California, Portola Valley, United States
Mentor Capital Partners Pennsylvania, United States, Yardley
Nanchang Daxue Kejiyuan Development China, Guangdong, Jiangxi
Nippon Television Holdings Japan, Tokyo
POCKET CARD Japan, Tokyo
Port of Amsterdam -
QCP Soteria -
Schroders England, London, United Kingdom
SGHF -
Thuasne -
Trammell Ventures Austin, Texas, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Solithor

Battery
Manufacturing
$11M16 May 2022 Genk, Limburg, Belgium

reMYND

Biotechnology
$14M21 Jan 2021 Leuven, Flemish Brabant, Belgium

Avantium Technologies

Biotechnology
Chemical
Pharmaceutical
Renewable Energy
$23M19 Apr 2016 North Holland
News
Kebony Raises €30M in Funding

– Kebony is a Oslo, Norway-based environmentally friendly wood modification technology company.
– The company raised €30m in funding.
– The round was led by Jolt Capital and Lightrock with participation from existing shareholders such as Goran, MVP, FPIM, PMV and Investinor.
– The new investment will be used to accelerate growth initiatives in core markets in Europe and the US.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent FPIM?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: